Latest Regeneron Pharmaceuticals Inc News

In this Friday, March 13, 2020 photo provided by Regneron, members of the Infectious Disease team celebrate at their lab in New York state after confirming cells from Singapore are viable and that some make antibodies that bind to the coronavirus, suggesting they may have the potential to block it. (Regeneron via AP)

One company's quest for an antibody drug to fight COVID-19

Dec. 21, 2020 12:05 AM EST

On a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems —...

A nurse walks COVID-19 tests back to the tent at the free COVID-19 testing site on Monday, Nov. 23, 2020 in Glenwood Springs, Colo. (Chelsea Self/Glenwood Springs Post Independent via AP)

The Latest: China reports results of mass testing

Nov. 23, 2020 10:56 PM EST

BEIJING — China has reported new coronavirus cases in the cities of Shanghai and Tianjin as it seeks to prevent small outbreaks from becoming larger ones. The National Health Commission said Tuesday that there were two new locally spread cases in the previous 24-hour period, one in each city. It also...

In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. The Food and Drug Administration on Saturday, Nov. 21, 2020 authorized the use of the Regeneron Pharmaceuticals Inc. drug to try to prevent patients with mild-to-moderate disease from worsening and needing hospitalization. It's given as a one-time treatment through an IV and is still going through more testing to establish its safety and effectiveness.  (Regeneron via AP)

FDA allows emergency use of antibody drug Trump received

Nov. 21, 2020 11:53 PM EST

U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month. The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc....